Literature DB >> 23158526

Pathogenesis of acute coronary syndromes.

Filippo Crea1, Giovanna Liuzzo.   

Abstract

Experimental models of atherogenesis have provided a growing body of information about molecular mechanisms of plaque growth; however, transition from coronary stability to instability is less well understood due to the lack of animal models reflective of human disease. The abrupt clinical presentation of acute coronary syndromes gives a strong signal of discontinuity in the natural history of atherothrombosis. The causes of such discontinuity are complex, probably multiple, and still largely unknown. A better knowledge of the causes of coronary instability might allow identification of new therapeutic targets aimed at the preservation of plaque stability in those subjects in whom primary prevention fails to prevent plaque growth. The goal of this review was to propose a pathogenetic classification of acute coronary syndromes that might help in the search of new diagnostic algorithms and therapeutic targets.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158526     DOI: 10.1016/j.jacc.2012.07.064

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

Review 1.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 2.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 3.  Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes.

Authors:  H Vernon Anderson; Robin Jacob
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

Review 4.  Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.

Authors:  Davide Flego; Giovanna Liuzzo; Cornelia M Weyand; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

5.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical Stability: An In Vivo Optical Coherence Tomography Study.

Authors:  Rocco Vergallo; Italo Porto; Domenico D'Amario; Gianmarco Annibali; Mattia Galli; Stefano Benenati; Francesco Bendandi; Stefano Migliaro; Francesco Fracassi; Cristina Aurigemma; Antonio Maria Leone; Antonino Buffon; Francesco Burzotta; Carlo Trani; Giampaolo Niccoli; Giovanna Liuzzo; Francesco Prati; Valentin Fuster; Ik-Kyung Jang; Filippo Crea
Journal:  JAMA Cardiol       Date:  2019-04-01       Impact factor: 14.676

7.  Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction (STEMI).

Authors:  Marjan Mahdavi-Roshan; Zeinab Ghorbani; Mahboobeh Gholipour; Arsalan Salari; Amir Savar Rakhsh; Jalal Kheirkhah
Journal:  BMC Cardiovasc Disord       Date:  2022-05-14       Impact factor: 2.174

8.  Effect of interleukin-2 level and genetic variants on coronary artery disease.

Authors:  Ru Ding; Wenwu Gao; David H Ostrodci; Zhiqing He; Yuanlin Song; Lan Ma; Chun Liang; Zonggui Wu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 9.  Interleukin-17 and acute coronary syndrome.

Authors:  Sheng-an Su; Hong Ma; Li Shen; Mei-xiang Xiang; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

10.  Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus.

Authors:  Daniela Pedicino; Giovanna Liuzzo; Francesco Trotta; Ada Francesca Giglio; Simona Giubilato; Francesca Martini; Francesco Zaccardi; Giuseppe Scavone; Marco Previtero; Gianluca Massaro; Pio Cialdella; Maria Teresa Cardillo; Dario Pitocco; Giovanni Ghirlanda; Filippo Crea
Journal:  J Diabetes Res       Date:  2013-05-23       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.